Caris Life Sciences, Inc. (CAI)

Caris Life Sciences will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Caris Life Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	-273.44	-378.26	-462.53
Depreciation & Amortization	45.66	55.97	54.38
Share-Based Compensation	-	18.64	15.24
Other Operating Activities	25.17	-37.92	-4.31
Operating Cash Flow	-202.61	-245.2	-276.1
Capital Expenditures	-9.4	-8.44	-22.32
Change in Investments	-	61.38	237.09
Investing Cash Flow	-9.4	52.93	214.77
Share Issuance / Repurchase	-	1.53	1.87
Debt Issued / Paid	-	199.82	10.57
Other Financing Activities	1.47	-1.06	-2.3
Financing Cash Flow	1.47	200.29	10.13
Net Cash Flow	-210.54	8.02	-51.13
Free Cash Flow	-212.01	-253.64	-298.42
Free Cash Flow Margin	-46.85%	-61.52%	-97.48%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).